Oculis Holding AG (OCS) Equity Ratio (2021 - 2025)
Quarterly Equity Ratio fell 32.98% to 248.72 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 248.72 through Dec 2025, down 32.98% year-over-year, with the annual reading at 248.72 for FY2025, 32.98% down from the prior year.
Oculis Holding AG's Equity Ratio history spans 5 years, with the latest figure at 248.72 for Q4 2025.
- Equity Ratio came in at 248.72 for Q4 2025, down from 371.1 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 371.1 in Q4 2024 to a low of 2.64 in Q4 2022.
- The 5-year median for Equity Ratio is 248.72 (2025), against an average of 187.32.
- Year-over-year, Equity Ratio tumbled 151.78% in 2022 and then surged 12221.1% in 2023.
- Oculis Holding AG's Equity Ratio stood at 1.05 in 2021, then crashed by 151.78% to 2.64 in 2022, then surged by 12221.1% to 320.5 in 2023, then grew by 15.79% to 371.1 in 2024, then tumbled by 32.98% to 248.72 in 2025.
- Per Business Quant, the three most recent readings for OCS's Equity Ratio are 248.72 (Q4 2025), 371.1 (Q4 2024), and 320.5 (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.73 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.77 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.21 |
| 10 | Oculis Holding AG | 24.51 Bn | 24.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 248.72 |
| Dec 31, 2024 | 371.10 |
| Dec 31, 2023 | 320.50 |
| Dec 31, 2022 | -2.64 |
| Dec 31, 2021 | -1.05 |